Hypoalbuminemia for the Prediction of Venous Thromboembolism and Treatment of Direct Oral Anticoagulants in Metastatic Gastric Cancer Patients

Gastric Cancer - Germany
doi 10.1007/s10120-019-00930-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Development of Treatment of Cancer-Associated Venous Thromboembolism With Direct Oral Anticoagulants

The Japanese Journal of Phlebology
2020English

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2019English

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

Recent Advances in the Treatment of Venous Thromboembolism in the Era of the Direct Oral Anticoagulants

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Recent Advances in the Treatment and Prevention of Venous Thromboembolism in Cancer Patients: Role of the Direct Oral Anticoagulants and Their Unique Challenges

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Derivation of the Non-Inferiority Margin for the Evaluation of Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism

Thrombosis Journal
Hematology
2013English

Potential Role of New Anticoagulants for Prevention and Treatment of Venous Thromboembolism in Cancer Patients

Vascular Health and Risk Management
2013English

New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities

Drugs
Pharmacology
2014English

All-Cause Mortality Risk With Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism

Thrombosis and Haemostasis
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy